| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |